The chemical class 'DIXDC1 Activators' primarily consists of molecules that modulate the Wnt/β-catenin signaling pathway, as direct chemical activators of DIXDC1 are not well characterized. These activators work predominantly by inhibiting glycogen synthase kinase 3 beta (GSK-3β), a key negative regulator of the Wnt pathway. Inhibition of GSK-3β leads to stabilization and accumulation of β-catenin in the cytoplasm, which subsequently translocates to the nucleus and activates Wnt target genes, including those regulated by DIXDC1.
The diversity among these chemicals ranges from traditional small molecule inhibitors like Lithium Chloride and BIO to more targeted compounds like LGK-974, which inhibits Wnt ligand secretion. Some of these activators, such as SkQ1, have broader cellular targets and may influence DIXDC1 activity by modulating cellular redox states and mitochondrial function, thereby indirectly affecting Wnt signaling. The impact of these chemicals on DIXDC1 is primarily through the modulation of the Wnt pathway, which is crucial for various cellular processes including cell proliferation, migration, and fate determination. The use of these activators in research contexts needs careful consideration of their broad effects on cellular signaling networks and the specific context of DIXDC1's role in these processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Activates the Wnt/β-catenin pathway by inhibiting GSK-3β, potentially enhancing DIXDC1 function. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
GSK-3β inhibitor that activates the Wnt/β-catenin pathway, which may indirectly activate DIXDC1. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
A selective GSK-3β inhibitor, potentially promoting Wnt pathway activation and influencing DIXDC1. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
Potent GSK-3β inhibitor, activating Wnt signaling and potentially influencing DIXDC1 activity. | ||||||
IWR-1-endo | 1127442-82-3 | sc-295215 sc-295215A | 5 mg 10 mg | $82.00 $135.00 | 19 | |
Inhibits Wnt response by stabilizing Axin, but its impact on Wnt signaling can indirectly modulate DIXDC1. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Inhibits Wnt production, indirectly affecting pathways involving DIXDC1. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
Inhibitor of Wnt ligand secretion, potentially altering DIXDC1 activity through Wnt signaling modulation. | ||||||
Wnt Synergist, QS11 | 944328-88-5 | sc-222417 sc-222417A | 5 mg 25 mg | $141.00 $607.00 | ||
Activator of Wnt/β-catenin signaling, could indirectly affect DIXDC1. | ||||||